LIGAND PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ligand Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • Ligand Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 18.1M shares, a 4.33% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 18.1M +751K +4.33% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 17.9M +790K +4.61% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 17.6M +605K +3.57% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 17.4M +527K +3.12% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 17.4M +470K +2.78% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 17.1M +273K +1.62% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 17M +184K +1.1% Dec 31, 2022 10-K 2024-02-29
Q3 2022 16.9M +187K +1.12% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 16.9M +206K +1.24% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 16.9M +209K +1.26% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 16.8M +687K +4.27% Dec 31, 2021 10-K 2023-02-28
Q3 2021 16.7M +616K +3.83% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 16.7M +605K +3.77% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 16.7M +602K +3.75% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 16.1M -743K -4.42% Dec 31, 2020 10-K 2022-02-28
Q3 2020 16.1M -1.47M -8.38% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 16.1M -3.32M -17.1% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 16.1M -3.61M -18.4% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 16.8M -3.94M -19% Dec 31, 2019 10-K 2021-02-24
Q3 2019 17.6M -3.53M -16.7% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 19.4M -1.71M -8.08% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 19.7M -1.64M -7.69% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 20.8M -383K -1.81% Dec 31, 2018 10-K 2020-02-27
Q3 2018 21.1M +338 +0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 21.1M +45.4K +0.22% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 21.3M +306K +1.46% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 21.1M +239K +1.15% Dec 31, 2017 10-K 2019-02-28
Q3 2017 21.1M +196K +0.94% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 21M +197K +0.94% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 21M +180K +0.87% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 20.9M +960K +4.81% Dec 31, 2016 10-K 2018-03-01
Q3 2016 20.9M +981K +4.92% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 20.9M +1.02M +5.12% Jun 30, 2016 10-Q/A 2016-11-15
Q1 2016 20.8M +1.16M +5.89% Mar 31, 2016 10-Q/A 2016-11-15
Q4 2015 19.9M +374K +1.91% Dec 31, 2015 10-K 2017-02-28
Q3 2015 19.9M -199K -0.99% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 19.8M -941K -4.53% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 19.7M -1.06M -5.11% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 19.6M -893K -4.37% Dec 31, 2014 10-K/A 2016-11-15
Q3 2014 20.1M -1.41M -6.56% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 20.8M -657K -3.07% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 20.7M -626K -2.93% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 20.5M -810K -3.81% Dec 31, 2013 10-K 2015-02-23
Q3 2013 21.5M +446K +2.11% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 21.4M Jun 30, 2013 10-Q 2013-08-01
Q1 2013 21.3M Mar 31, 2013 10-Q 2013-05-08
Q4 2012 21.3M +596K +2.88% Dec 31, 2012 10-K/A 2014-12-12
Q3 2012 21.1M Sep 30, 2012 10-Q 2012-11-14
Q4 2011 20.7M Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.